PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (JMAS) Fair Value & Analysis
Financial Services · ID · Market cap 228B IDR
Fair value as of: Jul 19, 2026
From 4 valuation models · updated 22 days ago
Share price −5.8% over the past month.
Below-average quality, and screening another 84% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (45.97 IDR). The favourable scenario is already priced in.
- Solid but not exceptional quality (45/100) and above fair value, neither a clear bargain nor a standout compounder.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 19, 2026.
How to read this chart
60‑month range 50.00 IDR – 328.00 IDR · fair‑value band 27.58 IDR – 45.97 IDR · the 228.00 IDR price screens above the 36.78 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 19, 2026.
Analysis
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (JMAS) currently trades at 228.00 IDR, while our model-based Fair Value estimate is 36.78 IDR, implying the stock looks roughly 83.9% overvalued today. The Quality Score stands at 45/100 (below-average quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk generated revenue of 77.2B IDR at a net margin of 7.0%. Revenue declined 19.1% year over year. It earns a return on equity of 2.5%. The balance sheet holds a net cash position of 41.2B IDR. Fundamentals as of Jul 19, 2026
Our scenario range runs from 27.58 IDR (bear case) to 45.97 IDR (bull case); at 228.00 IDR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 38% below its 52-week high and 88% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 1% fair-value upside, at -84%, JMAS screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 4 models by family
Widest divergence: Economic Profit (84.86 IDR) versus Multiples (36.78 IDR). Highest evidence: P/E Multiple (63).
Notify me when JMAS reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 53
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk engages in the sharia life insurance business in Indonesia. The company offers individual insurance which provides sharia financial planning solutions for individuals through various protection and investment products; and group insurance products that offers various life and health insurance products for …
Full company description
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk engages in the sharia life insurance business in Indonesia. The company offers individual insurance which provides sharia financial planning solutions for individuals through various protection and investment products; and group insurance products that offers various life and health insurance products for companies, government agencies, non-governmental organizations, and communities. PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk was founded in 2014 and is based in Jakarta Selatan, Indonesia. PT Asuransi Jiwa Syariah is a subsidiary of Kospin Jasa.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk reported revenue of 79.5B IDR in FY2024 versus 44.4B IDR in FY2020, a compound +15.7%/yr. Reported net income was 2.8B IDR in FY2024, compounding +169.9%/yr from FY2020.
of which total revenue +39.3 pp · buybacks/dilution −7.9 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
JMAS screens 84% overvalued. Compare with China Life Insurance Company →
Peer Group
Insurance - Life · 95 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Insurance - Life median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Insurance - Life stocks, each showing price versus our Fair Value estimate (as of Jul 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| China Life Insurance Company 601628 | ¥38.72 | ¥70.87 | +83% |
| Ping An Insurance (Group) Company 601318 | ¥49.60 | ¥96.76 | +95% |
| AIA Group 1299 | HK$75.55 | HK$7.88 | -90% |
| Manulife Financial Corporation MFC | C$58.52 | C$45.13 | -23% |
| Great-West Lifeco Inc GWO | C$92.34 | C$59.64 | -35% |
| Life Insurance Corporation LICI | ₹438.30 | ₹590.43 | +35% |
| Fubon Financial Holding 2881 | 124.50 TWD | 115.05 TWD | -8% |
| Cathay Financial Holding 2882 | 94.00 TWD | 94.95 TWD | +1% |
| Samsung Life Insurance Co 032830 | 337,500 KRW | 166,710 KRW | -51% |
| China Pacific Insurance (Group) Co 601601 | ¥29.75 | ¥59.50 | +100% |
Compare PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (JMAS) overvalued or undervalued?
What is the fair value of JMAS?
What is the quality score of JMAS?
What is the revenue of PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk (JMAS)?
What is the net profit margin of JMAS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PT Asuransi Jiwa Syariah Jasa Mitra Abadi Tbk and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.